About Jim Flynn
Form D filings for Elion Therapeutics in 2024 list Jim Flynn as director.
Jim Flynn first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jim Flynn in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jim Flynn works with at each company, as listed on that company's latest Form D.
Elion Therapeutics, Inc. · Form D, Jun 26, 2024
